ITSCRC 2023

September 07-10, 2023
Washington, DC

2023 International TSC Research Conference
Explore more Neuroscience congress materials
Material Type

Results(4)

Neuroscience
Behavioral outcomes of treatment with cannabidiol oral solution in individuals with seizures associated with tuberous sclerosis complex: design of an ongoing phase 4 trial (EpiCom)
Author(s): Agnies Van Eeghen MD, Emma Children’s Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands and Advisium's Heeren Loo, Amersfoort, The Netherlands
Neuroscience
View Oral Presentation
Co-creation of EpiCom phase 4 study design in collaboration with the tuberous sclerosis complex community of patients, caregivers, healthcare professionals, and a pharmaceutical company
Author(s): Lisa Moore-Ramdin MD, Jazz Pharmaceuticals
Neuroscience
View Poster
Long-term safety and efficacy of add-on cannabidiol for seizures associated with tuberous sclerosis complex: 3-year results from the GWPCARE6 open-label extension.
Author(s): Elizabeth Thiele MD, PhD, Massachusetts General Hospital
Neuroscience
View Poster
Long-term efficacy and safety of cannabidiol (CBD) in patients with tuberous sclerosis complex: 4-year results from the CBD Expanded Access Program
Author(s): Elizabeth Thiele MD, PhD, Massachusetts General Hospital
Neuroscience
View Poster